NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: Enfusion, Inc. (NYSE: ENFN)Click to Take Action Enfusion, Inc. has entered into a definitive agreement with Clearwater Analytics. The purchase price is $11.25 per share, delivered in an approximately equal mix of cash and stock. Edible Garden AG, Incorporated (NASDAQ: EDBL)Click to Take Action Edible Garden AG, Incorporated has entered into a non-binding Letter of Intent(LOI) to acquire Narayan and its subsidiaries. Under the LOI, Edible Garden will issue common stock to Narayan’s shareholders in exchange for full ownership, with Narayan’s shareholders expected to hold a majority of Edible Garden’s shares post-transaction. Singular Genomics Systems, Inc. (NASDAQ: OMIC)Click to Take Action Singular Genomics Systems, Inc. has entered into a definitive agreement with an affiliate of Deerfield Management Company L.P. for $20.00 per share. Upon completion, Singular Genomics will become a private company. Nordstrom, Inc. (NYSE: JWN)Click to Take Action Nordstrom, Inc. has entered into a merger agreement with Erik, Pete, Jamie Nordstrom and other members of the Nordstrom family and El Puerto de Liverpool, S.A.B. de C.V. for $24.25 in cash per share. The Nordstrom Family will hold majority ownership post-transaction. Why Your Participation Matters: SHAREHOLDER CASES: ADDRESSING THE INJUSTICE As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™ How to Get Involved: Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact the Firm at [email protected] or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law. Attorney advertising. Prior results do not guarantee similar outcomes. Contacts: Moon K. Young Chief of Operations Kuehn Law, PLLC 53 Hill Street, Suite 605 Southampton, NY 11968 [email protected] (833) 672-0814
Kuehn Law Encourages ENFN, EDBL, OMIC, and JWN Investors to Contact Law Firm
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...